The University of Chicago Header Logo

Connection

Emily Rogalski to Alzheimer Disease

Back to Details
This is a "connection" page, showing publications Emily Rogalski has written about Alzheimer Disease.
Emily Rogalski
Connection Strength
9.515
Alzheimer Disease
  1. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology. Acta Neuropathol Commun. 2022 08 09; 10(1):111.
    View in: PubMed
    Score: 0.610
  2. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia. Brain. 2022 06 30; 145(6):2133-2148.
    View in: PubMed
    Score: 0.606
  3. Functional decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2021 10; 17(10):1641-1648.
    View in: PubMed
    Score: 0.556
  4. Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia. Neurology. 2021 02 09; 96(6):e916-e925.
    View in: PubMed
    Score: 0.547
  5. Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease. Neurology. 2020 02 18; 94(7):e699-e704.
    View in: PubMed
    Score: 0.512
  6. Clinical and cortical decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2019 04; 15(4):543-552.
    View in: PubMed
    Score: 0.479
  7. Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology. 2016 Sep 27; 87(13):1337-43.
    View in: PubMed
    Score: 0.404
  8. The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias. Psychiatr Clin North Am. 2015 Jun; 38(2):333-52.
    View in: PubMed
    Score: 0.365
  9. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord. 2011 Apr-Jun; 25(2):159-63.
    View in: PubMed
    Score: 0.278
  10. Primary progressive aphasia: relationship between gender and severity of language impairment. Cogn Behav Neurol. 2007 Mar; 20(1):38-43.
    View in: PubMed
    Score: 0.209
  11. A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce. JAMA Netw Open. 2024 Aug 01; 7(8):e2427073.
    View in: PubMed
    Score: 0.175
  12. Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias. Acta Neuropathol Commun. 2024 Feb 22; 12(1):31.
    View in: PubMed
    Score: 0.170
  13. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024 02; 23(2):168-177.
    View in: PubMed
    Score: 0.169
  14. Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer's disease and aging. Nat Commun. 2024 Jan 18; 15(1):264.
    View in: PubMed
    Score: 0.169
  15. The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S74-S88.
    View in: PubMed
    Score: 0.166
  16. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S64-S73.
    View in: PubMed
    Score: 0.165
  17. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimers Dement. 2023 11; 19 Suppl 9:S98-S114.
    View in: PubMed
    Score: 0.165
  18. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S29-S41.
    View in: PubMed
    Score: 0.164
  19. Sex and APOE e4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S49-S63.
    View in: PubMed
    Score: 0.163
  20. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimers Dement. 2023 11; 19 Suppl 9:S89-S97.
    View in: PubMed
    Score: 0.163
  21. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimers Dement. 2023 11; 19 Suppl 9:S115-S125.
    View in: PubMed
    Score: 0.163
  22. Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S42-S48.
    View in: PubMed
    Score: 0.162
  23. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement. 2023 11; 19 Suppl 9:S8-S18.
    View in: PubMed
    Score: 0.161
  24. Learning slopes in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S19-S28.
    View in: PubMed
    Score: 0.161
  25. Evaluating the association between genetically proxied ACE inhibition and dementias. Alzheimers Dement. 2023 09; 19(9):3894-3901.
    View in: PubMed
    Score: 0.160
  26. Differential vulnerability of the dentate gyrus to tauopathies in dementias. Acta Neuropathol Commun. 2023 01 03; 11(1):1.
    View in: PubMed
    Score: 0.157
  27. Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging. J Neurosci. 2022 11 09; 42(45):8587-8594.
    View in: PubMed
    Score: 0.154
  28. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods. Alzheimers Dement. 2022 08; 18(8):1449-1460.
    View in: PubMed
    Score: 0.145
  29. Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2021 11; 17(11):1788-1797.
    View in: PubMed
    Score: 0.143
  30. Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance. Cereb Cortex. 2021 06 10; 31(7):3177-3183.
    View in: PubMed
    Score: 0.141
  31. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 12; 17(12):2043-2055.
    View in: PubMed
    Score: 0.140
  32. Nosology of Primary Progressive Aphasia and the Neuropathology of Language. Adv Exp Med Biol. 2021; 1281:33-49.
    View in: PubMed
    Score: 0.137
  33. Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology. J Neuropathol Exp Neurol. 2020 12 04; 79(12):1379-1381.
    View in: PubMed
    Score: 0.136
  34. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic Versus Aphasic Dementia. J Int Neuropsychol Soc. 2020 10; 26(9):927-931.
    View in: PubMed
    Score: 0.131
  35. APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort. Neurology. 2020 02 11; 94(6):e607-e612.
    View in: PubMed
    Score: 0.126
  36. What are the later life contributions to reserve, resilience, and compensation? Neurobiol Aging. 2019 11; 83:140-144.
    View in: PubMed
    Score: 0.126
  37. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease. Brain Pathol. 2020 03; 30(2):332-344.
    View in: PubMed
    Score: 0.125
  38. Introduction to the de Toledo Morrell special issue. Hippocampus. 2019 05; 29(5):407-408.
    View in: PubMed
    Score: 0.122
  39. Von Economo neurons of the anterior cingulate across the lifespan and in Alzheimer's disease. Cortex. 2018 02; 99:69-77.
    View in: PubMed
    Score: 0.110
  40. Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia. Alzheimers Dement. 2017 May; 13(5):598-601.
    View in: PubMed
    Score: 0.104
  41. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol. 2014 Oct; 10(10):554-69.
    View in: PubMed
    Score: 0.088
  42. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain. 2014 Apr; 137(Pt 4):1176-92.
    View in: PubMed
    Score: 0.085
  43. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain. 2012 May; 135(Pt 5):1554-65.
    View in: PubMed
    Score: 0.075
  44. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008 Jun; 63(6):709-19.
    View in: PubMed
    Score: 0.057
  45. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch Neurol. 2008 Feb; 65(2):244-8.
    View in: PubMed
    Score: 0.056
  46. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease. Brain Pathol. 2021 01; 31(1):189-204.
    View in: PubMed
    Score: 0.034
  47. Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia. JAMA Neurol. 2016 07 01; 73(7):846-52.
    View in: PubMed
    Score: 0.025
  48. Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity. J Neurosci. 2015 Jan 28; 35(4):1781-91.
    View in: PubMed
    Score: 0.023
  49. Verbal and nonverbal memory in primary progressive aphasia: the Three Words-Three Shapes Test. Behav Neurol. 2013; 26(1-2):67-76.
    View in: PubMed
    Score: 0.020
  50. Quantitative template for subtyping primary progressive aphasia. Arch Neurol. 2009 Dec; 66(12):1545-51.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.